NCI Advisors Approve Recompetition Of $132 Million Proteomic Network

From The Cancer Letter, March 12, 2010:

In a hotly debated decision, an NCI advisory group approved the institute’s plan to continue an extramural research program using mass spectrometry to discover biomarkers for cancer.

However, the NCI Board of Scientific Advisors mandated that the concept for the $132.5 million five-year program be rewritten and resubmitted to a subcommittee for final approval.

The project in question is a recompetition of grants for the Clinical Proteomic Technology Assessment for Cancer network. Five research teams were initially funded in 2006 under the first phase of the program to develop and standardize mass spectrometry technologies for biomarker studies. Under the recompetition, NCI would fund six to eight U24 awards and issue contracts for a data coordinating center and the production of biospecimens and reagents.

For the rest of the story, click on The Cancer Letter Archive at left to read the March 12, 2010 issue (subscription or day pass required).


_____
tags: NCI|  research funding